Health Law Alliance is publishing this alert to inform pharmacies and providers of a significant enforcement trend that could have serious implications for your business operations. ESI has drastically increased the number of audits it conducts of telehealth relationships, including providers that have contractual relationships with a provider named EZScripts. If you are doing business with EZScripts or other telehealth platforms, you will be subject to increased scrutiny from ESI and other PBMs.
Claim Phishing Audits on the Rise
Telehealth platforms often use pharmacies' National Provider Identifier (NPI) number to run "test" claims, often referred to as benefits eligibility checks.
PBMs and other entities involved in the claims adjudication process, such as McKesson's RelayHealth "switch," typically use "terms and conditions" and other contractual provisions to prohibit these transmissions.
ESI is now attempting to recoup on claims that are associated with these eligibility checks, irrespective that the claims are reversed and not paid. Specifically, ESI is demanding that pharmacies repay the entire amount at issue, meaning the entire dollar value arising from both paid and test claims.
This situation is deeply concerning. ESI is not only reclaiming all reimbursements made to these pharmacies, but also seeking to recover the monetary value of test claims for which pharmacies were never reimbursed, placing the financial stability of numerous pharmacies in jeopardy.
We Defend You Against ESI
If your pharmacy has done business with telehealth platforms such as Noble or EZScripts, and you have received an audit notice from ESI, we strongly urge you to contact us immediately. Our experienced PBM audit attorneys will provide you with a free consultation to discuss your options and provide the legal guidance necessary to protect your pharmacy from potentially devastating financial repercussions. Schedule a free consultation now.
MORE ARTICLES BY CATEGORY
Texas Moves to Rein in Ketamine Therapy—And Other States are Likely Next
The regulatory environment surrounding ketamine therapy is entering a new phase of maturity and enforcement. Recently, the Texas Medical Board published proposed regulations governing ketamine therapy, one of the first comprehensive regulatory frameworks in the country.
Read More >>California Hospice Fraud Crackdown: What it Means for Providers & How to Protect Your Business
California’s hospice fraud crackdown is only the beginning of what CMS and Medi-Cal regulators have claimed will be many more cases brought against hospice facilities and home health agencies. Providers who do not timely respond to a suspension or revocation may waive important rights. Act now to protect your business and reputation from governmental overreach based on data mining and other unreliable sources.
Read More >>New Executive Order Signals Faster Psychedelic Drug Approvals--and Closer DEA Scrutiny
On Saturday, April 18, President Trump signed an executive order designed to accelerate federal drug approvals for psychedelic drugs, a move experts are calling a significant win for patient access. But for ketamine providers and practices offering ketamine-assisted psychotherapy (KAP), increased coordination among regulators means increased scrutiny is inevitable. In this article, we break down what this executive order means for the future of regulatory enforcement.
Read More >>The WISeR Model: A New Era of Prior Authorization and Audit Risks for Wound Care
On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) officially launched the Wasteful and Inappropriate Service Reduction (WISeR) Model. This initiative is not just another administrative hurdle; it is a technology-driven enforcement overhaul aimed directly at the wound care industry.
Read More >>
